Skip to main content
. 2020 Oct 14;17:153. doi: 10.1186/s12985-020-01427-6

Table 1.

Clinical epidemiological data on the prevalence of HPgV among blood donors

Variable/category Total HPgV+ HPgV p-value
n (%) n (%) n (%)
Age (years)
18–30 224 48.8 37 16.5 187 83.5 p = 0.0273
31–50 197 42.9 18 9.1 179 90.9
 ≥ 51 38 8.3 2 5.3 36 94.7
Skin color
Brown 356 77.6 47 13.2 309 86.8 p = 0.462
White 84 18.3 9 10.7 75 89.3
Black 19 4.1 1 5.3 18 94.7
Sex
Male 284 61.9 45 15.8 241 84.9 p = 0.0056
Female 175 38.1 12 6.9 161 92.0
Education (years of study)
 ≥ 12 146 31.8 35 24.0 111 76.0 p < 0.0001
9 to 11 259 56.4 19 7.3 240 92.7
 ≤ 8 54 11.8 3 5.6 51 94.4
Co-infection
HIV+  120 26.1 32 26.7 88 73.3 p < 0.0001
HIV−  339 73.9 25 7.4 314 92.6